Baheal Medical

Qingdao Baheal Medical INC. (referred to as "Baheal Medical", stock code: 301015) was established in 2005 and is a leading health brand commercialization platform in the A-share market. Its core business focuses on the brand operation and development of high-quality pharmaceutical and healthcare products globally, effectively optimizing medical scenarios through technological innovation. Relying on its core capabilities in category insights and brand building, digital marketing, and ecosystem-based organizational collaboration, Baheal Medical has built a "Brand Highway," providing upstream industrial enterprises with full-channel commercialization solutions to enhance operational efficiency and promote the standardized development of the industry. After more than a decade of accumulation, Baheal Medical has formed a powerful marketing network, cooperating with over 14,000 large and medium-sized hospitals and nearly 400,000 pharmacies. It has incubated multiple category-leading brands, with a product portfolio covering four major categories: OTC and general health products, OTX and other prescription drugs, critical disease medications such as oncology drugs, and high-end medical devices, forming stable cooperative relationships with hundreds of upstream enterprises.